BC
MET icon

Barrett & Company’s MetLife MET Stock Holding History

Barrett & Company’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$785K Buy
11,093
+39
+0.4% +$2.92K 0.27% 56
2025
Q4 		$873K Sell
11,054
-140
-1% -$11.1K 0.29% 54
2025
Q3 		$922K Buy
11,194
+34
+0.3% +$2.68K 0.32% 52
2025
Q2 		$898K Buy
11,160
+33
+0.3% +$2.55K 0.34% 52
2025
Q1 		$893K Sell
11,127
-815
-7% -$67.8K 0.38% 46
2024
Q4 		$978K Buy
11,942
+121
+1% +$10.1K 0.41% 41
2024
Q3 		$975K Sell
11,821
-1,957
-14% -$146K 0.42% 41
2024
Q2 		$967K Buy
13,778
+46
+0.3% +$3.28K 0.44% 42
2024
Q1 		$1.02M Sell
13,732
-257
-2% -$17.9K 0.48% 38
2023
Q4 		$925K Buy
13,989
+47
+0.3% +$2.94K 0.5% 42
2023
Q3 		$877K Sell
13,942
-953
-6% -$59.4K 0.52% 42
2023
Q2 		$842K Buy
14,895
+105
+0.7% +$5.83K 0.49% 42
2023
Q1 		$857K Buy
14,790
+86
+0.6% +$5.8K 0.54% 39
2022
Q4 		$1.06M Hold
14,704
– – 0.7% 32
2022
Q3 		$1.06M Buy
+14,704
New +$939K 0.7% 32

Other funds holding MET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Barrett & Company's MET Position: Q1 2026 in Review

Barrett & Company increased its MetLife (MET) stake by 0.35% in Q1 2026, buying an estimated $2.92K and bringing the position to 11,093 shares worth $785K. The position accounts for 0.27% of the portfolio, ranked #56.

Barrett & Company first reported a position in MET in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.06M in Q4 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Barrett & Company held 11,093 shares of MetLife worth $785K as of Q1 2026.
  • Barrett & Company bought 39 MetLife shares in Q1 2026, an estimated $2.92K.
  • MetLife made up 0.27% of Barrett & Company's portfolio in Q1 2026, its #56 holding.
  • Barrett & Company first reported a position in MetLife in Q3 2022 and has held it in 15 quarters since.
  • Barrett & Company's MetLife position peaked at $1.06M in Q4 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.